About Pi-Cardia
Pi-Cardia is a company based in Rehovot (Israel) founded in 2009 by Erez Golan and Eyal Kolka. Pi-Cardia has raised $40 million across 3 funding rounds from investors including Clal Biotechnology Industries, Jacques Séguin and Sofinnova Partners. Pi-Cardia offers products and services including ShortCut Device and Leaflex Performer. Pi-Cardia operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation, among others.
- Headquarter Rehovot, Israel
- Founders Erez Golan, Eyal Kolka
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40 M (USD)
in 3 rounds
-
Latest Funding Round
$27 M (USD), Series D
Apr 20, 2020
-
Investors
Clal Biotechnology Industries
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pi-Cardia
Pi-Cardia offers a comprehensive portfolio of products and services, including ShortCut Device and Leaflex Performer.
Tool for splitting bioprosthetic valve leaflets to prevent obstruction.
Device for next-generation aortic repair in heart disease.
People of Pi-Cardia
Unlock access to complete
Funding Insights of Pi-Cardia
Pi-Cardia has successfully raised a total of $40M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $27 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pi-Cardia
Pi-Cardia has secured backing from 5 investors, including angel and venture fund investors. Prominent investors backing the company include Clal Biotechnology Industries, Jacques Séguin and Sofinnova Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Life Sciences focused VC firm investing in Israel and the US
|
Locked | Locked | Locked | |
|
VC firm investing in seed and early stage companies in Italy
|
Locked | Locked | Locked |
Investor details for Pi-Cardia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pi-Cardia
Investment portfolio details for Pi-Cardia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pi-Cardia
Detailed financials for Pi-Cardia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pi-Cardia Comparisons
Peer comparison for Pi-Cardia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pi-Cardia
Pi-Cardia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| Locked | Locked | Locked |
Smart medical devices for heart valve diseases are developed.
|
Detailed competitors of Pi-Cardia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pi-Cardia
Complete news archive for Pi-Cardia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pi-Cardia
Pi-Cardia was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Pi-Cardia is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Erez Golan is the current CEO of Pi-Cardia. They have also founded this company.
Pi-Cardia is a funded company, having raised a total of $40M across 3 funding rounds to date.
Pi-Cardia was established in 2009 in Rehovot, Israel, within the medical device sector focused on cardiology. Non-implant solutions for valve repair are produced, including the Leaflex device. Separation between calcium deposits on valve leaflets is created by its scoring lines, which restores leaflet flexibility, supports mobility, and enhances overall valve hemodynamics. Operations center on advancing treatments for structural heart conditions.
Pi-Cardia's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Pi-Cardia offers ShortCut Device and Leaflex Performer.
Pi-Cardia has 5 investors. Key investors include Clal Biotechnology Industries, Jacques Séguin, Sofinnova Partners, Innogest Capital, and VI Ventures.